Occurrence of Comorbidities before and after Soft Tissue Sarcoma Diagnosis

Table 1

Characteristics of newly diagnosed patients with soft tissue sarcoma.

Characteristics	Patients with soft tissue sarcoma (𝑁=533)
	N (%)
Gender
Male	266 (50)
Female	267 (50)
Age in years
<50	180 (34)
50–<70	211 (40)
≥70	142 (27)
mean ± SD	56 (±20)
Location
Extremities	190 (36)
Head and neck	77 (14)
Thorax	97 (18)
Abdomen or (retro)peritoneum	91 (17)
Overlapping sites and NOS	78 (15)
Histology
Fibrosarcoma (ICD-O-3: 8810-4)	17 (3)
Malignant fibrous hystiocytoma	28 (5)
(ICD-O-3: 8830)
Dermatofibrosarcoma	27 (5)
(ICD-O-3: 8832-3)
Liposarcoma (ICD-O-3: 8850-8)	77 (14)
Leiomyosarcoma (ICD-O-3: 8890-1)	84 (16)
Rhabdomyosarcoma	17 (3)
(ICD-O-3: 8900-1, 8910, 8920)
Synovial sarcoma (ICD-O-3: 9040-3)	9 (2)
Hemangiosarcoma (ICD-O-3: 912,	22 (4)
913, 915)
Malignant peripheral nerve sheath	16 (3)
tumor (ICD-O-3: 9540, 9560)
Sarcoma, other	63 (12)
Sarcoma, NOS (ICD-O-3: 8800)	173 (32)
Treatment^1,2
Surgery	437 (82)
Chemotherapy	55 (10)

SD: standard deviation; NOS: not otherwise specified; ¹no data on radiotherapy available; ²defined during the first six months after soft tissue sarcoma diagnosis.